Skip to main content

Research Repository

Advanced Search

Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial

Hull, Mark A.; Sprange, Kirsty; Hepburn, Trish; Tan, Wei; Shafayat, Aisha; Rees, Colin J.; Clifford, Gayle; Logan, Richard F.; Loadman, Paul M; Williams, Elizabeth A; Whitham, Diane; Montgomery, Alan A.; seAFOod Collaborative Group

Authors

Mark A. Hull

Wei Tan

Colin J. Rees

Gayle Clifford

Richard F. Logan

Paul M Loadman

Elizabeth A Williams

Diane Whitham

ALAN MONTGOMERY ALAN.MONTGOMERY@NOTTINGHAM.AC.UK
Director, nottingham Clinical Trials Unit

seAFOod Collaborative Group



Abstract

© 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
Background
The omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) and aspirin both have proof of concept for colorectal cancer chemoprevention, aligned with an excellent safety profile. Therefore, we aimed to test the efficacy of EPA and aspirin, alone and in combination and compared with a placebo, in individuals with sporadic colorectal neoplasia detected at colonoscopy.
Methods
In a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial, patients aged 55–73 years who were identified during colonoscopy as being at high risk in the English Bowel Cancer Screening Programme (BCSP; ≥3 adenomas if at least one was ≥10 mm in diameter or ≥5 adenomas if these were

Citation

Hull, M. A., Sprange, K., Hepburn, T., Tan, W., Shafayat, A., Rees, C. J., …seAFOod Collaborative Group. (2018). Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial. Lancet, 392(10164), 2583-2594. https://doi.org/10.1016/S0140-6736%2818%2931775-6

Journal Article Type Article
Acceptance Date Nov 19, 2018
Online Publication Date Nov 19, 2018
Publication Date Nov 19, 2018
Deposit Date Nov 21, 2018
Publicly Available Date Nov 22, 2018
Journal Lancet
Print ISSN 0140-6736
Publisher Elsevier
Peer Reviewed Peer Reviewed
DOI https://doi.org/10.1016/s0140-6736%2818%2931775-6
Keywords General Medicine
Public URL https://nottingham-repository.worktribe.com/output/1297453
Publisher URL https://www.sciencedirect.com/science/article/pii/S0140673618317756?via%3Dihub